Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium

Mona G Arafa,1,2 Germeen NS Girgis,3 Marwa S El-Dahan3 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt; 2Chemotherapeutic Unit, Mansoura University Hospitals, Mansoura 35516, Egypt; 3Departme...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Arafa MG, Girgis GNS, El-Dahan MS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	atorvastatin calcium nanoparticles plga chitosan ocular thermosensitive gel. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/e5690b1b0c9840f197628ac6f36c168b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e5690b1b0c9840f197628ac6f36c168b
record_format	dspace
spelling	oai:doaj.org-article:e5690b1b0c9840f197628ac6f36c168b2021-12-02T15:26:53ZChitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium1178-2013https://doaj.org/article/e5690b1b0c9840f197628ac6f36c168b2020-02-01T00:00:00Zhttps://www.dovepress.com/chitosan-coated-plga-nanoparticles-for-enhanced-ocular-anti-inflammato-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Mona G Arafa,1,2 Germeen NS Girgis,3 Marwa S El-Dahan3 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt; 2Chemotherapeutic Unit, Mansoura University Hospitals, Mansoura 35516, Egypt; 3Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EgyptCorrespondence: Mona G Arafa Suez Desert Road, El Sherouk City, Cairo Governorate 11837, EgyptTel +20 1005055557Fax +20 226300010Email mona.arafa@bue.edu.egBackground: Atorvastatin calcium (AT) is an ocular anti-inflammatory with limited bioavailability when taken orally due to its low solubility in low pH and extensive first-pass effect. To overcome these problems, AT was entrapped in polymeric nanoparticles (NPs) to improve surface properties and sustained release, in addition to achieving site-specific action.Methods: AT was entrapped in chitosan (CS)-coated polylactic-co-glycolic acid (PLGA) NPs to form AT-PLGA-CS-NPs (F1). F1 and free AT were embedded in thermosensitive Pluronic® 127-hydroxypropyl methylcellulose (HPMC) to form thermosensitive gels (F2) and (F3) while F4 is AT suspension in water. F1 was assessed for size, surface charge, polydispersity index (PDI), and morphology. F2 and F3 were examined for gelation temperature, gel strength, pH, and viscosity. In vitro release of the four formulations was also investigated. The ocular irritancy and anti-inflammatory efficacy of formulations against prostaglandin E1-(PGE1) induced ocular inflammation in rabbits were investigated by counting the polymorphonuclear leukocytes (PMNs) and protein migrated in tears.Results: Oval F1 of 80.0– 190.0± 21.6 nm exhibited a PDI of 0.331 and zeta potential of &rlm; 17.4± 5.62 mV with a positive surface charge. F2 and F3 gelation temperatures were 35.17± 0.22°C and 36.93± 0.31°C, viscosity 12,243± 0.64 and 9759± 0.22 cP, gel strength 15.56± 0.6 and 12.45± 0.1 s, and pHs of 7.4± 0.02 and 7.4± 0.1, respectively. In vitro release of F1, F2, F3, and F4 were 48.21± 0.31, 26.48± 0.5, 84.76± 0.11, and 100% after 24 hrs, respectively. All formulations were non-irritant. F2 significantly inhibited lid closure up to 3 h, PMN counts and proteins in tear fluids up to 5 h compared to other formulations.Conclusion: AT-PLGA-CS-NP thermosensitive gels proved to be successful ocular anti-inflammatory drug delivery systems.Keywords: atorvastatin calcium, nanoparticles, PLGA, chitosan, ocular, thermosensitive gelArafa MGGirgis GNSEl-Dahan MSDove Medical Pressarticleatorvastatin calciumnanoparticlesplgachitosanocularthermosensitive gel.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1335-1347 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	atorvastatin calcium nanoparticles plga chitosan ocular thermosensitive gel. Medicine (General) R5-920
spellingShingle	atorvastatin calcium nanoparticles plga chitosan ocular thermosensitive gel. Medicine (General) R5-920 Arafa MG Girgis GNS El-Dahan MS Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
description	Mona G Arafa,1,2 Germeen NS Girgis,3 Marwa S El-Dahan3 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt; 2Chemotherapeutic Unit, Mansoura University Hospitals, Mansoura 35516, Egypt; 3Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EgyptCorrespondence: Mona G Arafa Suez Desert Road, El Sherouk City, Cairo Governorate 11837, EgyptTel +20 1005055557Fax +20 226300010Email mona.arafa@bue.edu.egBackground: Atorvastatin calcium (AT) is an ocular anti-inflammatory with limited bioavailability when taken orally due to its low solubility in low pH and extensive first-pass effect. To overcome these problems, AT was entrapped in polymeric nanoparticles (NPs) to improve surface properties and sustained release, in addition to achieving site-specific action.Methods: AT was entrapped in chitosan (CS)-coated polylactic-co-glycolic acid (PLGA) NPs to form AT-PLGA-CS-NPs (F1). F1 and free AT were embedded in thermosensitive Pluronic® 127-hydroxypropyl methylcellulose (HPMC) to form thermosensitive gels (F2) and (F3) while F4 is AT suspension in water. F1 was assessed for size, surface charge, polydispersity index (PDI), and morphology. F2 and F3 were examined for gelation temperature, gel strength, pH, and viscosity. In vitro release of the four formulations was also investigated. The ocular irritancy and anti-inflammatory efficacy of formulations against prostaglandin E1-(PGE1) induced ocular inflammation in rabbits were investigated by counting the polymorphonuclear leukocytes (PMNs) and protein migrated in tears.Results: Oval F1 of 80.0– 190.0± 21.6 nm exhibited a PDI of 0.331 and zeta potential of &rlm; 17.4± 5.62 mV with a positive surface charge. F2 and F3 gelation temperatures were 35.17± 0.22°C and 36.93± 0.31°C, viscosity 12,243± 0.64 and 9759± 0.22 cP, gel strength 15.56± 0.6 and 12.45± 0.1 s, and pHs of 7.4± 0.02 and 7.4± 0.1, respectively. In vitro release of F1, F2, F3, and F4 were 48.21± 0.31, 26.48± 0.5, 84.76± 0.11, and 100% after 24 hrs, respectively. All formulations were non-irritant. F2 significantly inhibited lid closure up to 3 h, PMN counts and proteins in tear fluids up to 5 h compared to other formulations.Conclusion: AT-PLGA-CS-NP thermosensitive gels proved to be successful ocular anti-inflammatory drug delivery systems.Keywords: atorvastatin calcium, nanoparticles, PLGA, chitosan, ocular, thermosensitive gel
format	article
author	Arafa MG Girgis GNS El-Dahan MS
author_facet	Arafa MG Girgis GNS El-Dahan MS
author_sort	Arafa MG
title	Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
title_short	Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
title_full	Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
title_fullStr	Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
title_full_unstemmed	Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
title_sort	chitosan-coated plga nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/e5690b1b0c9840f197628ac6f36c168b
work_keys_str_mv	AT arafamg chitosancoatedplgananoparticlesforenhancedocularantiinflammatoryefficacyofatorvastatincalcium AT girgisgns chitosancoatedplgananoparticlesforenhancedocularantiinflammatoryefficacyofatorvastatincalcium AT eldahanms chitosancoatedplgananoparticlesforenhancedocularantiinflammatoryefficacyofatorvastatincalcium
_version_	1718387236852989952

Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium

Ejemplares similares